<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA082490-0055</title>
	</head>
	<body>
		<main>
			<p><P> August 24, 1990, Friday, Home Edition  </P> <P> BRIEFLY  </P> <P> SmithKline, Rugby to Sell Generic Dyazide: SmithKline Beecham Pharmaceuticals  will make a generic form of its popular high blood pressure drug to be  distributed by Rugby Laboratories, the companies said.  </P> <P> SmithKline Beecham will continue providing Dyazide under its brand-name for  those who want it. Rugby will ship the generic capsules to pharmacies, chains  and wholesalers by Oct. 1. Generic competitors for Dyazide, one of the most  widely prescribed drugs in the country, have been absent from the marketplace  since Bolar Pharmaceutical Co. earlier this year withdrew its version.  </P></p>
		</main>
</body></html>
            